University Of British Columbia
Rheumatoid arthritis trials often fail to report health inequities
Randomized controlled trials for rheumatoid arthritis in Canada often fail to report determinants of health inequity among their participants, according to data published in Arthritis Care & Research.
Lifetime medical costs of sickle cell disease total $1.7 million
Privately insured individuals with sickle cell disease spend about $1.7 million on disease-related medical expenses during their lifetime, according to study results published in Blood Advances.
Early severe asthma exacerbations affect disease course, future risk for attacks
Severe exacerbations that occur early in the course of asthma impacted the course of the disease and risk for subsequent exacerbations in children and adults, researchers reported in the Annals of the American Thoracic Society.
Pandemic-related stress linked to increase in ovulatory disturbances among women
ATLANTA — Stress related to the COVID-19 pandemic was associated with an increase in subclinical ovulatory disturbances among women without a change in menstrual cycle length, according to a speaker at ENDO 2022.
Angiotensin receptor blockers tied to less ventilation, vasopressors in men with COVID-19
Use of angiotensin receptor blockers was associated with less need for ventilation and vasopressors among men hospitalized with COVID-19, but not in women, according to research presented at the Society of Critical Care Medicine Congress.
Niraparib regimen ‘new first-line option’ for certain men with metastatic prostate cancer
SAN FRANCISCO — The addition of niraparib to abiraterone acetate and prednisone improved outcomes for certain men with prostate cancer, according to randomized phase 3 study results presented at ASCO Genitourinary Cancers Symposium.
Olaparib regimen benefits men with metastatic castration-resistant prostate cancer
SAN FRANCISCO — The addition of olaparib to abiraterone acetate significantly extended radiographic PFS as first-line treatment for metastatic castration-resistant prostate cancer, according to an interim analysis of the randomized phase 3 PROpel study.
Real-world data show oral immunotherapy for peanut allergy is safe, effective in infants
In a real-world setting, peanut oral immunotherapy was safer in infants aged 12 months or younger than in children aged 1 to 5 years, according to recent data.
Labetalol may be best option for pregnant women with hypertension
Among antihypertensive medications commonly prescribed for pregnant women, all reduced risk for severe hypertension, but labetalol also reduced odds of other poor outcomes, researchers reported.